
About Okeiro
Okeiro is a Healthcare company based in Paris (France) founded in 2023 by Pierrick Arnal and Alexandre Loupy. Okeiro has raised $10.98 million across 1 funding round from investors including Alven, Forepont Capital Partners and Red River West. Its chief executive, as recorded, is Pierrick Arnal. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring.
Company details
Provider of AI-powered predictive analytics for transplant and chronic disease management. This platform uses predictive algorithms validated for clinical care and research to improve patient monitoring. It offers tools for healthcare professionals to anticipate clinical changes, enabling proactive interventions. Patients benefit from improved medical follow-up and enhanced communication with caregivers. Pharmaceutical companies can leverage the platform to accelerate clinical trials through faster evaluation of research results. The technology centralizes data, providing a clear, instant overview and intelligent alerts to detect early warning signs of complications. A dedicated nurse supports telehealth monitoring, freeing up clinicians time. The platform also facilitates research through virtualized clinical trials and the use of predictive models.
- Headquarters Paris, France
- Founders Pierrick Arnal, Alexandre Loupy
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website okeiro.com/en
- Social LinkedIn
- Total Equity Funding$10.98M (USD)
in 1 rounds
- Latest Funding Round$10.98M (USD), Series A
Apr 2025
- InvestorsAlven
& 2 more
Funding Insights of Okeiro
Okeiro has successfully raised a total of $10.98M through 1 strategic funding round. The most recent funding activity was a Series A round of $10.98 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.98M
- Total Rounds 1
- Last Round Series A β $10.98M
- First Round $10.98M
(Apr 2025)
- Investors Count 3
All 1 funding rounds of Okeiro with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2025 | $10.98M | Series A | β | Alven, Forepont Capital Partners | β |
3 investors in total: 3 institutional.
Investors in Okeiro
Okeiro has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Alven, Forepont Capital Partners and Red River West.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are targeted by Alven, a venture capital firm. | alven.co | Paris, France | ||
| forepont.com | ||||
European tech companies are supported for U.S. market expansion. | redriverwest.com |
Investor details for Okeiro
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Okeiro
3 people are tracked at Okeiro (3 in leadership).
| Name | Role | Group |
|---|---|---|
Thierry Beaupere | Co-Fondateur | Leadership |
Pierrick Arnal | Co-Founder & CEO | Leadership |
Alexandre Loupy | Co-Founder | Leadership |
Complete people profiles for Okeiro
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Okeiro
2 dated milestones of Okeiro across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Okeiro is founded.
- Funding First funding round of $11.0M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Okeiro
Okeiro was founded in 2023 and raised its 1st funding round 2 years after it was founded.
Okeiro is headquartered in Paris, France.
Pierrick Arnal is the CEO of Okeiro, as recorded in our data. They have also founded this company.
Okeiro is a funded company, having raised a total of $10.98M across 1 funding round to date. The company's 1st funding round was a Series A of $10.98M, raised on Apr 2025.
Provider of AI-powered predictive analytics for transplant and chronic disease management. This platform uses predictive algorithms validated for clinical care and research to improve patient monitoring. It offers tools for healthcare professionals to anticipate clinical changes, enabling proactive interventions. Patients benefit from improved medical follow-up and enhanced communication with caregivers. Pharmaceutical companies can leverage the platform to accelerate clinical trials through faster evaluation of research results. The technology centralizes data, providing a clear, instant overview and intelligent alerts to detect early warning signs of complications. A dedicated nurse supports telehealth monitoring, freeing up clinicians time. The platform also facilitates research through virtualized clinical trials and the use of predictive models.
Okeiro has 3 investors. Key investors include Alven, Forepont Capital Partners, and Red River West.